Search research articles
Contact Us
Filters
Showing results (91-100 of 361) with videos related to
Page
of 37
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2019
Germline and Somatic Mutations in Prostate Cancer for the Clinician
Heather H Cheng, Alexandra O Sokolova, Edward M Schaeffer, et al.
Cancer Reports (Hoboken, N.J.)
|
February 23, 2021
Examining reporting and representation of patients with cancer in COVID-19 clinical trials
Maya Rabow, Christine Wang, Sylvia Zhang, et al.
Cancer
|
June 1, 2006
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy
Brian I Rini, Vivian Weinberg, Lawrence Fong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Progression-free survival as a predictor of overall survival in men with castrate-resistant prostate cancer
Susan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2004
Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer
Celestia S Higano, Nicholas J Vogelzang, Jeffrey A Sosman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer
Eric J Small, N Simon Tchekmedyian, Brian I Rini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study
Charles J Ryan, Susan Halabi, San-San Ou, et al.
The Journal of Urology
|
October 16, 2007
Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome
Charles J Ryan, Vivian Weinberg, Jonathan Rosenberg, et al.
JAMA Oncology
|
October 27, 2022
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic
Meera V Ragavan, Nichole Legaspi, Alyssa LaLanne, et al.
Urology
|
August 11, 2004
Impact of race on survival in men with metastatic hormone-refractory prostate cancer
Susan Halabi, Eric J Small, Nicholas J Vogelzang, et al.
Page
of 37
Search research articles
Search
Showing results (91-100 of 361) with videos related to
Sort By:
Page
of 37
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2019
Germline and Somatic Mutations in Prostate Cancer for the Clinician
Heather H Cheng, Alexandra O Sokolova, Edward M Schaeffer, et al.
Cancer Reports (Hoboken, N.J.)
|
February 23, 2021
Examining reporting and representation of patients with cancer in COVID-19 clinical trials
Maya Rabow, Christine Wang, Sylvia Zhang, et al.
Cancer
|
June 1, 2006
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy
Brian I Rini, Vivian Weinberg, Lawrence Fong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Progression-free survival as a predictor of overall survival in men with castrate-resistant prostate cancer
Susan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2004
Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer
Celestia S Higano, Nicholas J Vogelzang, Jeffrey A Sosman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer
Eric J Small, N Simon Tchekmedyian, Brian I Rini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study
Charles J Ryan, Susan Halabi, San-San Ou, et al.
The Journal of Urology
|
October 16, 2007
Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome
Charles J Ryan, Vivian Weinberg, Jonathan Rosenberg, et al.
JAMA Oncology
|
October 27, 2022
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic
Meera V Ragavan, Nichole Legaspi, Alyssa LaLanne, et al.
Urology
|
August 11, 2004
Impact of race on survival in men with metastatic hormone-refractory prostate cancer
Susan Halabi, Eric J Small, Nicholas J Vogelzang, et al.
Page
of 37